Infectious toxicity using alemtuzumab

MeSH terms

• 2-Aminopurine / analogs & derivatives
• 2-Aminopurine / therapeutic use
• Alemtuzumab
• Antibiotic Prophylaxis
• Antibodies, Monoclonal / administration & dosage
• Antibodies, Monoclonal / adverse effects*
• Antibodies, Monoclonal / pharmacology
• Antibodies, Monoclonal / therapeutic use
• Antibodies, Monoclonal, Humanized
• Antibodies, Monoclonal, Murine-Derived
• Antibodies, Neoplasm / adverse effects*
• Antibodies, Neoplasm / pharmacology
• Antigens, CD / immunology
• Antigens, Neoplasm / immunology
• Antineoplastic Agents / adverse effects*
• Antineoplastic Agents / pharmacology
• Bone Marrow Transplantation
• CD52 Antigen
• Clinical Trials as Topic
• Cytomegalovirus Infections / etiology
• Cytomegalovirus Infections / immunology
• Cytomegalovirus Infections / prevention & control
• Disease Susceptibility
• Famciclovir
• Ganciclovir / therapeutic use
• Glycoproteins / antagonists & inhibitors
• Glycoproteins / immunology
• Graft vs Host Disease / prevention & control
• Humans
• Immunologic Deficiency Syndromes / chemically induced*
• Immunosuppressive Agents / adverse effects*
• Immunosuppressive Agents / pharmacology
• Incidence
• Infections / etiology*
• Lymphoproliferative Disorders / drug therapy
• Opportunistic Infections / etiology
• Opportunistic Infections / prevention & control
• Pneumonia, Pneumocystis / etiology
• Pneumonia, Pneumocystis / immunology
• Pneumonia, Pneumocystis / prevention & control
• Rituximab
• Transplantation Conditioning
• Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use
• Viremia / etiology
• Viremia / immunology
• Viremia / prevention & control
• Virus Activation